$10 million has been set aside to develop a vaccine for strep-throat - a precursor to rheumatic fever and rheumatic heart disease.
Last year more than a hundred people were hospitalised for the first time with rheumatic fever, mostly Māori and Pasifika children.
New Zealand is one of the few developed countries to still have the preventable illness so prevalent in the community.
Emma Hatton reports.
